Assessment of 1,3-Butadiene Mutagenicity in the Bone Marrow of B6C3F1 lacl Transgenic Mice (Big Blue®): A Review of Mutational Spectrum and lacl Mutant Frequency After a 5-Day 625 ppm 1,3-Butadiene Exposure

Environmental and Molecular Mutagenesis

Volumn 28, Issue 4, 1996, Pages 424-429

  Recio, Leslie ^a   Meyer, Kathy G ^a   Pluta, Linda J ^a   Moss, Owen R ^a   Saranko, Christopher J ^b  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

1,3 butadiene; Bone marrow; lacl transgene; Mutational spectrum

Indexed keywords

MUS MUSCULUS;

1,3 BUTADIENE; 1,3 BUTADIENE DERIVATIVE; 1,3-BUTADIENE; BACTERIAL PROTEIN; ESCHERICHIA COLI PROTEIN; LACI PROTEIN, BACTERIA; MUTAGENIC AGENT; REPRESSOR PROTEIN;

ANIMAL; ARTICLE; BONE MARROW; DRUG EFFECT; GENETICS; INHALATIONAL DRUG ADMINISTRATION; MALE; MOUSE; MUTAGEN TESTING; MUTATION; TIME; TRANSGENIC MOUSE;

ADMINISTRATION, INHALATION; ANIMALS; BACTERIAL PROTEINS; BONE MARROW; BUTADIENES; ESCHERICHIA COLI PROTEINS; MALE; MICE; MICE, TRANSGENIC; MUTAGENICITY TESTS; MUTAGENS; MUTATION; REPRESSOR PROTEINS; TIME FACTORS;

EID: 0030331126     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2280(1996)28:4<424::aid-em18>3.0.co;2-h     Document Type: Article

References (44)

1. Adler I-D, Anderson D (1994): Dominant lethal effects after inhalation exposure to 1,3-butadiene. Mutat Res 309:295-297.
2. Adler I-D, Cao J, Filser JG, Gassner P, Kessler W, Kleisch U, Neuhäuser-Klaus A, Nüsse M (1994): Mutagenicity of 1,3-butadiene inhalation in somatic and germinal cells of mice. Mutat Res 309:307-314.
3. Adler I-D, Cochrane J, Osterman-Golkar S, Skopek TR, Sorsa M, Vogel E (1995a): 1,3-Butadiene working group report. Mutat Res 330:101-114.
4. Adler I-D, Filser JG, Gassner P, Kessler W, Schöneich J, Schriever-Schwemmer G (1995b): Heritable translocations induced by exposure of male mice to 1,3-butadiene. Mutat Res 347:121-127.
5. Adler I-D, Kliesch U, Tiveron C, Pacchierotti F (1995c): Clastogenicity of diepoxybutane in bone marrow cells and male germ cells of mice. Mutagenesis 10:535-541.
6. Autio K, Renzi L, Catalan J, Albrecht OE, Sorsa M (1994): Induction of micronuclei in peripheral blood and bone marrow erythrocytes of rats and mice exposed to 1,3-butadiene by inhalation. Mutat Res 309:315-320.
7. Bird AP (1986): CpG-rich islands and the function of DNA methylation. Nature 321:209-213.
8. Bond JA, Recio L, Andjelkovich D (1995): Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace. Carcinogenesis 16:165-171.
9. Citti L, Gervasi PG, Turchi G, Bellucci G, Bianchini R (1984): The reaction of 3,4-epoxy-1-butene with deoxyguanosine and DNA in vitro: Synthesis and characterization of the main adducts. Carcinogenesis 5:47-52.
10. Cochrane JE, Skopek TR (1994a): Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15:713-717.
11. Cochrane JE, Skopek TR (1994b): Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis 15:719-723.
12. Cunningham MJ, Choy WN, Arce GT, Rickard LB, Vlachos DA, Kinney LA, Sarrif AM (1986): In vivo sister chromatid exchange and micronucleus induction studies with 1,3-butadiene in B6C3F1 mice and Sprague-Dawley rats. Mutagenesis 1:449-452.
13. Goodrow T, Reynolds S, Maronpot R, Anderson M (1990): Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene. Cancer Res 50:4818-4823.
14. Gorelick NJ, Andrews JL, Gu M, Glickman BW (1995): Mutational spectra in skin from 7,12-dimethylbenz[a]anthracene-treated and untreated transgenic mice. Mol Carcinogen 14:53-62.
15. Gossen JA, Martus H-J, Wei JY, Vijg J (1995): Spontaneous and x-ray-induced deletion mutations in a lacZ plasmid-based transgenic mouse model. Mutat Res 331:89-97.
16. Greenwell A, Sills R, Soderkvist P, Wiseman RA (1994). Characterization of p53 mutations by immunohistochemistry, single strand conformation analysis and DNA sequencing in B6C3F1 exposed to 1,3-butadiene. Abstract 520. Toxicologist 14:147.
17. Heddle JA, Shaver-Walker P, Tao KS, Zhang XB (1995): Treatment protocols for transgenic mutation assays in vivo. Mutagenesis 10:467-470.
18. Himmelstein MW, Turner MJ, Asgharian B, Bond JA (1994): Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis 15:1479-1486.
19. Himmelstein MW, Acquavella JF, Recio L, Medinsky MA, Bond JA (1996): Toxicology and epidemiology of 1,3-butadiene. CRC Rev Toxicol (in press).
20. Huff JE, Melnick RL, Solleveld HA, Haseman JK, Powers M, Miller RA (1985): Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science 227:548-549.
21. International Agency for Research on Cancer (IARC) (1992): "1,3-Butadiene. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Occupational Exposures to Mists and Vapours from Strong Inorganic Acids and Other Industrial Chemicals," vol. 54. Lyon: IARC, pp 237-285.
22. Jacobson-Kram D, Rosenthal SL (1995): Molecular and genetic toxicology of 1,3-butadiene. Mutat Res 121-130.
23. Knoll A, Jacobson DP, Kretz PL, Lundberg KS, Short JM, Sommer SS (1994): Spontaneous mutations in lacl-containing lambda lysogens derived from transgenic mice: The observed patterns differ in liver and spleen. Mutat Res 311:57-67.
24. Kohler SE, Provost GS, Freck A, Kretz PL, Bullock WO, Sorge JA, Putman DL, Short J (1991): Spectra of spontaneous and mutagen-induced mutations in the lacl gene in transgenic mice. Proc Natl Acad Sci USA 88:7958-7962.
25. 32P-postlabelling of butadiene monoepoxide N6-adenine adducts. Carcinogenesis 16:2999-3007.
26. 32P-postlabelling. Carcinogenesis 15:1903-1910.
27. Melnick RL, Kohn MC (1995): Mechanistic data indicate that 1,3-butadiene is a human carcinogen. Carcinogenesis 16:157-163.
28. Melnick RL, Huff J, Chou BJ, Miller RA (1990a): Carcinogenicity of 1,3-butadiene in B6C3F1 mice at low exposure concentrations. Cancer Res 50:6592-6599.
29. Melnick RL, Huff JE, Roycroft JH, Chou BJ, Miller RA (1990b): Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6C3F1 mice following 65 weeks of exposure. Environ Health Perspect 86:27-36.
30. National Toxicology Program (NTP) (1984): "Toxicology and Carcinogenesis Studies of 1,3-Butadiene in B6C3F1 Mice (Inhalation Studies). Technical Report 228. Research Triangle Park, NC: National Toxicology Program.
31. Owen PE, Glaister JR (1990): Inhalation toxicity and carcinogenicity of 1,3-butadiene in Sprague-Dawley rats. Environ Health Perspect 86:19-25.
32. Recio L, Meyer K (1995): Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1 lacl transgenic mice exposed to 1,3-butadiene. Environ Mol Mutagen 26:1-8.
33. Recio L, Osterman-Golkar S, Csanady GA, Turner MJ, Myhr B, Moss O, Bond JA (1992): Determination of mutagenicity in tissues of transgenic mice following exposure to 1,3-butadiene and N-ethyl-N-nitrosourea. Toxicol Appl Pharmacol 117:58-64.
34. Seaton MJ, Follansbee MH, Bond JA (1995): Oxidation of butadiene monoepoxide by cDNA-expressed human cytochrome P450 2E1 and 3A4, and human, mouse and rat liver microsomes. Carcinogenesis 16:2287-2293.
35. 7-guanosine adducts of butadiene monoxide. Chem Res Toxicol 9:126-132.
36. Sisk S, Pluta LJ, Bond JA, Recio L (1994): Molecular analysis of lacl mutants from hone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene. Carcinogenesis 15:471-477.
37. Sorsa M, Peltonen K, Anderson D, Demopoulos NA, Neumann H-G, Osterman-Golkar S (1996): Assessment of environmental and occupational exposures to butadiene as a model for risk estimation of petrochemical emissions. Mutagenesis 11:9-17.
38. Tao KS, Heddle JA (1994): The accumulation and persistence of somatic mutations in vivo. Mutagenesis 9:187-191.
39. Tates AD, van Dam FJ, de Zwart FA, van Teylingen CMM, Natarajan AT (1994): Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene. Mutat Res 309:299-306.
40. Tice RR, Boucher R, Luke CA, Shelby MD (1987): Comparative cytogenetic analysis of bone marrow damage induced in male B6C3F1 mice by multiple exposures to gaseous 1,3-hutadiene. Environ Mutagen 9:235-250.
41. US Environmental Protection Agency (EPA) (1990): "Cancer Risk From Outdoor Exposure to Air Toxics," vol. 2, Appendices (EPA-4501/1-90-004b), Washington DC: EPA.
42. van Delft JH, Baan RA (1995): Germ cell mutagenesis in lambda lacZ transgenic mice treated with ethylnitrosourea: Comparison with the specific locus test. Mutagenesis 10:209-214.
43. Walker VE, Fennell TR, Upton PB, Skopek TR, Prevost V, Shuker DEC, Swenherg JA (1992): Molecular dosimetry of ethylene oxide: Formation and persistence of 7-(2-hydroxyethyl)guanine in DNA following repeated exposures of rats and mice. Cancer Res 52:4328-4334.
44. Xiao Y, Tates AD (1995): Clastogenic effects of 1,3-butadiene and its metabolites 1,2-epoxybutene and 1,2.3,4-diepoxybutane in splenocytes and germ cells of rats and mice in vivo. Environ Mol Mutagen 26:97-108.